Reuters: Pfizer turns up defense of smoking cessation drug

[NaDiNe]

Pfizer turns up defense of smoking cessation drug
      

NEW YORK (Reuters) - Pfizer Inc on Thursday turned up public relations efforts to defend its drug to help smokers quit after a recent report said there have been hundreds of problems with patients taking Chantix since its 2006 approval.
<p>You are not allowed to view links. Register or Login</p><div class="feedflare">
You are not allowed to view links. Register or Login You are not allowed to view links. Register or Login You are not allowed to view links. Register or Login
</div><img src="You are not allowed to view links. Register or Login" height="1" width="1"/>
      

You are not allowed to view links. Register or Login